Clinical Chemistry, Malmö
31 – 40 of 1337
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma
- Contribution to journal › Article
-
Mark
Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness
(2025) In European Journal of Nuclear Medicine and Molecular Imaging
- Contribution to journal › Article
-
Mark
Melanoma Proteomics Unveiled : Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
- Contribution to journal › Article
-
Mark
Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer
(2025) In Journal of the National Cancer Institute
- Contribution to journal › Article
-
Mark
Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing
(2025) In JAMA Oncology
- Contribution to journal › Article
-
Mark
Practical handling of hemolytic, icteric and lipemic samples for coagulation testing in European laboratories. A collaborative survey from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
- Contribution to journal › Article
- 2024
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
- Contribution to journal › Article
-
Mark
Elevated FVIII levels in hereditary hemorrhagic telangiectasia : Implications for clinical management
- Contribution to journal › Article
-
Mark
Potential subtype-specific therapeutic approaches in small cell lung cancer
- Contribution to journal › Scientific review
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
- Contribution to journal › Article
